183 related articles for article (PubMed ID: 2540093)
1. PAF-acether and experimental anaphylaxis as a model for asthma.
Pretolani M; Lellouch-Tubiana A; Lefort J; Bachelet M; Vargaftig BB
Int Arch Allergy Appl Immunol; 1989; 88(1-2):149-53. PubMed ID: 2540093
[TBL] [Abstract][Full Text] [Related]
2. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists.
Lellouch-Tubiana A; Lefort J; Simon MT; Pfister A; Vargaftig BB
Am Rev Respir Dis; 1988 Apr; 137(4):948-54. PubMed ID: 3281530
[TBL] [Abstract][Full Text] [Related]
3. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
Pretolani M; Lefort J; Malanchère E; Vargaftig BB
Eur J Pharmacol; 1987 Aug; 140(3):311-21. PubMed ID: 3653247
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor (PAF) and PAF antagonists in asthma.
Hosford D; Mencia-Huerta JM; Braquet P
Crit Rev Ther Drug Carrier Syst; 1990; 7(3):261-73. PubMed ID: 2073689
[TBL] [Abstract][Full Text] [Related]
5. Use of steroidal antiinflammatory drug provides further evidence for a potential role of PAF-acether in bronchial anaphylaxis.
Chignard M; Le Còuedic JP; Andersson P; Brange C
Int Arch Allergy Appl Immunol; 1986; 81(2):184-5. PubMed ID: 3759260
[TBL] [Abstract][Full Text] [Related]
6. Interactions between granulocytes and platelets with the guinea-pig lung in passive anaphylactic shock. Correlations with PAF-acether-induced lesion.
Lellouch-Tubiana A; Lefort J; Pfister A; Vargaftig BB
Int Arch Allergy Appl Immunol; 1987; 83(2):198-205. PubMed ID: 3583412
[TBL] [Abstract][Full Text] [Related]
7. Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether.
Detsouli A; Lefort J; Vargaftig BB
Br J Pharmacol; 1985 Apr; 84(4):801-10. PubMed ID: 4005486
[TBL] [Abstract][Full Text] [Related]
8. Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection.
Pretolani M; Lefort J; Vargaftig BB
Am Rev Respir Dis; 1988 Dec; 138(6):1572-8. PubMed ID: 3202509
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs.
Lellouch-Tubiana A; Lefort J; Pirotzky E; Vargaftig BB; Pfister A
Br J Exp Pathol; 1985 Jun; 66(3):345-55. PubMed ID: 3890915
[TBL] [Abstract][Full Text] [Related]
10. Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs.
Coëffier E; Borrel MC; Lefort J; Chignard M; Broquet C; Heymans F; Godfroid JJ; Vargaftig BB
Eur J Pharmacol; 1986 Nov; 131(2-3):179-88. PubMed ID: 3816952
[TBL] [Abstract][Full Text] [Related]
11. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.
Desquand S; Touvay C; Randon J; Lagente V; Vilain B; Maridonneau-Parini I; Etienne A; Lefort J; Braquet P; Vargaftig BB
Eur J Pharmacol; 1986 Aug; 127(1-2):83-95. PubMed ID: 3019727
[TBL] [Abstract][Full Text] [Related]
12. Protection by nedocromil sodium of active immunization-induced bronchopulmonary alterations in the guinea pig.
Pretolani M; Lefort J; Silva P; Malanchere E; Dumarey C; Bachelet M; Vargaftig BB
Am Rev Respir Dis; 1990 May; 141(5 Pt 1):1259-65. PubMed ID: 2160213
[TBL] [Abstract][Full Text] [Related]
13. The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs.
Fitzgerald MF; Moncada S; Parente L
Br J Pharmacol; 1986 May; 88(1):149-53. PubMed ID: 3708213
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba.
Touvay C; Etienne A; Braquet P
Agents Actions; 1986 Jan; 17(3-4):371-2. PubMed ID: 3754380
[TBL] [Abstract][Full Text] [Related]
15. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
Coëffier E; Joseph D; Vargaftig BB
J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
[TBL] [Abstract][Full Text] [Related]
16. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis.
Berti F; Omini C; Rossoni G; Braquet P
Pharmacol Res Commun; 1986 Sep; 18(9):775-93. PubMed ID: 3099317
[TBL] [Abstract][Full Text] [Related]
17. Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis.
Darius H; Lefer DJ; Smith JB; Lefer AM
Science; 1986 Apr; 232(4746):58-60. PubMed ID: 3082008
[TBL] [Abstract][Full Text] [Related]
18. Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021.
Touvay C; Vilain B; Taylor JE; Etienne A; Braquet P
Prog Lipid Res; 1986; 25(1-4):277-88. PubMed ID: 2827186
[No Abstract] [Full Text] [Related]
19. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
Sanz MJ; Weg VB; Walsh DT; Williams TJ; Nourshargh S
Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the platelet activating factor mediated component of guinea pig anaphylaxis by receptor antagonists.
Darius H; Smith JB; Lefer AM
Int Arch Allergy Appl Immunol; 1986; 80(4):369-75. PubMed ID: 3015804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
